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Abstract
Background: Tobacco smoking is still a worldwide health risk. Current pharmacotherapies have at best, a success
rate of no more than 50%. Auricular (ear) acupressure has been purported to be beneficial in achieving smoking
cessation in some studies, while in others has been deemed insignificant. We hereby describe the protocol for a
three-arm randomised controlled trial to examine the possible benefits of self-administered acupressure for
smoking cessation.
Methods: Sixty consenting participants with confirmed habit of tobacco smoking will be recruited and
randomized into three arms to receive either auricular acupressure at five true acupoints (NADA protocol), auricular
acupressure at five sham points, or no auricular acupressure at all. Participants having auricular acupressure will
exert firm pressure to each acupoint bilaterally via the bead in the attached plasters whenever they feel the urge
to smoke. The treatment phase will last for six weeks during which all participants will be assessed weekly to
review their smoking log, state of abstinence, end-exhalation carbon monoxide levels and possible adverse effects
including withdrawal reactions and stress levels. At any time, a successful quit date will be defined with continuous
abstinence for the following consecutive 7 days. From then on, participants will be evaluated individually for
continuous abstinence rate (CAR), end-exhalation carbon monoxide levels and adverse effects of stress and
withdrawal at specified intervals up to 26 weeks. Expectancy of treatment will be assessed with a four-item
Borkovec and Nau self-assessment credibility scale during and after intervention.
Discussion: We incorporate validated outcome measures of smoking cessation into our randomised controlled trial
design with the objectives to evaluate the feasibility and possible benefits of self-administered auricular
acupressure as a non-invasive alternative to pharmacotherapy for smoking cessation.
Trial Registration: ClinicalTrials.gov: NCT01389622 (registered Jul 7 2011)
Background
Problem of tobacco smoking
Despite a decreasing trend in some countries, tobacco
smoking is still prevalent in about one third of our
world’s population [1] and it remains a major modifiable
health hazard with causative links to increased cardio-
vascular and pulmonary morbidity. It is also associated
with lung cancer, oral cancer, laryngeal carcinoma, eso-
phageal carcinoma, hepatocellular carcinoma, pancreatic
carcinoma, bladder cancer and cervical carcinoma[2,3].
In Southeast Asia region, there has been a disturbing
increase in adolescent smoking[4]. In 2006, it has been
estimated that the annual death toll due to tobacco
smoking approached 5 million, and is expected to be
doubled by 2030[5]. Unfortunately, success of tobacco
control is very much predicated by political constraints
and the varying efficacies of smoking cessation strategies
in any given locality.
Methods of smoking cessation
Various methods of smoking cessation are available and
can be broadly divided into pharmacological and non-
pharmacological methods, which often work better in
combination[6]. Nicotine replacement therapy is one of
the commonest prescribed treatments which enhances the
overall rate of quitting by 50-70%[7] with a stand-alone
success rate of 6-20%[8-10]. Newer oral medications
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[12], which significantly improve smoking abstinence with
a higher success rate of 30-50%[11-14]. Thus said, the
quote success rates may vary according to the length of
continuous abstinence which can range from 3 months to
2 years.
Auricular acupuncture and smoking cessation
Use of acupuncture for smoking cessation has been prac-
tised during the last five decades and its efficacy has been
quoted as approaching 45%, which is on par with other
pharmacological methods[15]. Auricular (ear) acupuncture
is a popular variant with varying degrees of reported effi-
cacy. The practice of auricular acupuncture is based on
t h et h e o r yt h a tt h e r ea r es p e c i f i cp o i n t so nt h ea u r i c l e
which correspond to major organs or systems of the
human body; and they can be manipulated by acupuncture
or acupressure to exert a therapeutic effect upon the cor-
responding target organ or system. An excellent review
has been published by Chen in 1993[16]. A recent study
shows that electro-stimulation of certain auricular points
can modulate vagal activity[17]. A map of commonly used
auricular points is included in Figure 1. For smoking
cessation, there are various suggested protocols and the 5-
points National Acupuncture Detoxification Association
(NADA) protocol is the most widely adopted one (5 anno-
tated arrows in Figure 1).
A literature search from all available PubMed listings
using the following keywords “Auricular acupuncture” and
“smoking” only returns 35 entries with the earliest report
of a letter in French in 1975[18]. Since then studies have
shown[19-23] conflicting results ranging from statistically
significant advantage[23] to not effective as compared to
placebo[19,21]. Earlier Cochrane reviews in 2000[24] and
2002[25] both asserted that there was no clear evidence
for acupuncture in auricular or non-auricular form for
smoking cessation. However, since then clinical data
[26-29] has continued to report significant benefits of auri-
cular acupuncture and this led Cochrane Review to amend
its position in a meta-analysis conducted in 2006, which
concluded that “auricular acupuncture appears to be effec-
tive for smoking cessation, but the effect may not depend
on point location”[30].
Auricular acupressure versus needle auricular
acupuncture
In the literature, there are two types of auricular acupunc-
ture: with needle inserted into the acupoints or with pres-
sure exerted at the acupoints via plastered beads. Needle
auricular acupuncture involves skin penetration and car-
ries the usual risks for acupuncture, i.e., hematoma and
infection which may lead to otitis externa[31], auricular
chondritis and ear deformity[32] or even subacute bacter-
ial endocarditis[33]. Auricular acupressure via plastered
beads is relatively non-invasive and can be self-adminis-
tered by the recipient at times required. According to the
published literature, auricular acupressure has comparable
efficacy versus needle auricular acupuncture[30].
To date smoking cessation studies using auricular pres-
sure have been sparse with conflicting results, from no
better than sham[34,35] to clinically significant [26,36].
However in those studies, the number and choice of auri-
cular points were not standardised and different types of
sham treatments were used. Moreover, the outcome
measures (i.e., definition of successful abstinence) were
not uniform. In view of this, we design our randomised
controlled pilot study to test the hypothesis that self-
administered auricular acupressure is a safe and feasible
method for smoking cessation, with the aim to calculate
the sample and effect size for future randomised double-
blind placebo controlled trials.
Methods/design
Study aim
To demonstrate that self-administered acupressure at
verum auricular acupoints is a safe and feasible option
for smoking cessation, and when administered at verum
Figure 1 Auricular points as they are used in acupuncture. The
five auricular points chosen according to the National Acupuncture
Detoxification Association (NADA) protocol: Autonomic Point (1);
Shen Men (2); C. Kidney (3); Liver (4); Lung 2 (5).
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pressure on non-acupoints and that without acupressure.
Study design
This is a pilot study designed as a 3-arm randomised
controlled trial. Eligible participants will be recruited
from Queen’s University Family Health Team (QUFHT)
out-patient clinics as per inclusion and exclusion criteria.
They will be randomly allocated to self-administered
auricular acupressure at true points, self-administered
auricular acupressure at sham points, or no auricular
acupressure at all. Figure 2 provides an outline of the
study.
Recruitment
R e c r u i t m e n to fp a r t i c i p a n t sw i l lb eb a s e da tt h eo u t -
patient clinics of the Queen’s University Family Health
Team (QUFHT) in Kingston, Ontario, Canada. Informa-
tion pamphlet will be placed in the clinics’ waiting areas,
supplemented by posters and appropriate referral from
physicians in the QUFHT. Respondents will be contacted
by research assistants from the Centre of Studies in Pri-
mary Care (CSPC) and then invited to an initial screening
visit for eligibility.
Inclusion criteria
Participants are considered eligible if they satisfy the fol-
lowing criteria:
￿ Male or female, between 18 and 75 years of age
inclusive, and able to provide informed consent
￿ History of tobacco cigarette smoking for at least
6 months.
￿ Confirmed intention of smoking cessation with no
more than 2 previous failed attempts in the last 3 years
Exclusion criteria
Participants will be excluded if they have:
￿ Doubts about smoking cessation
￿ Existing pharmacotherapy for smoking cessation
￿ History of major psychiatric disorder or chronic pain
syndromes
￿ More than 2 failed attempts of smoking cessation in
the previous 3 years, either with pharmacological meth-
ods or any forms of acupuncture/acupressure.
￿ History of substance abuse
￿ History of atopy, or suspected/known allergy to
plaster
Sample size calculation and randomisation
A convenience sample size of a total of 60 participants
will be recruited, with 20 participants per arm after ran-
domisation. Compared to other pilot studies, this sample
size is deemed sufficient and appropriate statistical meth-
ods will be adopted to accommodate for foreseeable lim-
itations during final analysis (see section on statistical
analysis). Randomisation and allocation of subjects will
be performed according to the CONSORT standards in
terms of randomisation type[37], randomisation genera-
tion[38], allocation concealment[39]. All participants will
be informed that they will be randomly allocated to one
of the three study arms using a computer generated
sequence created by the SPSS 11.0 (IBM
© SPSS
© Statis-
tics, NY, USA). The random allocation will only be dis-
closed on the date of treatment commencement. Apart
from Arm 3 (passive controls with no acupressure),
blinding will be ensured in participants of Arm 1 (true
acupuncture points) and Arm 2 (sham points). In parti-
cular, participants receiving acupressure will be told that
the actual points chosen may vary over time to eliminate
guessing amongst them during the study. Efforts will also
be made to avoid contacts between all participants.
Auricular acupressure
Auricular acupressure will be administered by research
assistants and staff nurses who will attend a one-day
training course. They will be naïve to the differences
between the true and sham acupressure points, and will
be advised not to discuss anything with the participants.
Their competence and point accuracy will be assessed
before the start of the study and periodically thereafter
by the research team and two licenced practitioners in
acupuncture.
Verum acupressure (arm 1)
Participants in Arm 1 will receive a 2 mm × 2 mm acu-
pressure plaster (each with a single Melastoma candidum
seed, see Figure 3a and 3b) at each of the 5 auricular acu-
points bilaterally (Lung 2, Shen Men, Autonomic Point,
Liver and C. Kidney) according to the NADA protocol
(Figure 1). Participants will be instructed to exert firm
digital pressure to each acupoint for five seconds via the
Figure 2 Flow chart of proposed pilot study.
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smoke. The seeded plasters are water resistant and should
remain in position until the next weekly scheduled review,
when they will be replaced with new ones. If the plasters
detach, the participants will return to the research center
for replacement without delay. Period of intervention will
be six weeks (week 2 to week 7).
Sham acupressure (Arm2)
As active controls, participants in Arm 2 will receive iden-
tical acupressure plasters bilaterally as in Arm 1 except
that the 5 auricular points are randomly chosen with none
belonging to the NADA points, or any other true acupres-
sure points that have been described. If in doubt, the prin-
cipal investigators will be consulted. As in Arm 1,
participants in Arm 2 will also be instructed to exert firm
digital pressure to every acupoint via the plastered seeds
for five seconds whenever they feel the urge to smoke.
Similarly, if the plasters detach at any time of the study,
they need to be replaced without delay. Period of treat-
ment will be six weeks (week 2 to week 7).
Control arm (Arm3)
Participants in Arm 3 will serve as passive controls and
no acupressure plasters will be administered. For six
weeks (week 2 to week 7) they will be given advice and
counselling support for smoking cessation during the
weekly review, and will be assessed for outcome measures
as with the participants in the other two study arms.
Co-existent treatment
A record of co-existent treatments, both pharmacologi-
cal and non-pharmacological, will be recorded for every
participant. Any treatment pertaining to smoking cessa-
tion should be discontinued at the start of the run-in
week and will not be resumed until the participant com-
pleted the study or is withdrawn from the study due to
treatment failure or adverse events. Equally, all partici-
pants will be advised not to attempt any smoking cessa-
tion 2 weeks before the run-in period.
Baseline evaluation
Once eligibility is confirmed, all participants will
undergo a pre-treatment baseline evaluation during
week 1 (run-in period). All subjects will be subjected to
a brief physical examination recording the weight,
height, body-mass-index (BMI), waist circumference,
resting blood pressure, resting heart rate and end-
expiratory carbon monoxide level (CO) through the use
of a hand-held Smoklyzer
©. In addition, a brief history
will be taken regarding their past and present health.
Their smoking profile will also be assessed in terms of
number of cigarettes smoked per day, smoking history
in terms of pack-years, number of previous attempts of
smoking cessation and methods used, and finally, their
level of motivation to quit on Likert scale of 0-7.
Outcome measures
The primary outcome measures in our study will be 7-
day point prevalent abstinence rate (PAR), continuous
abstinence rate (CAR), end-expiratory carbon monoxide
levels (CO), nicotine withdrawal symptoms according to
the Minnesota Nicotine Withdrawal Scale (MNWS) and
stress level according to the Stress Check List (SCL).
PAR is defined as abstinence from tobacco smoking for
the previous 7 days, whereas CAR is defined as absti-
n e n c es i n c et h et a r g e tq u i td a t e .T h et i m et a k e n( T )t o
reach the quit date is also recorded. During the active
intervention period (week 2 to week 7), the following
will be assessed weekly: number of cigarettes smokes
per day, CO, MNWS and SCL. At week 3, 5 and 7,
CAR and PAR will be assessed. At week 13 and week
26, successful quitters will be assessed for CO, PAR,
SCL and MNWS. At week 2 and week 8/one week after
successful quitting, expectancy of treatment will be
assessed in all participants with a modified 4-item Bor-
kovec and Nau self-assessment credibility scale as
adopted by Tough et al. [40] in acupuncture related
studies.
Statistical analysis
Baseline characteristics of participants (age, number of
cigarettes smoked per day, history of packed-years and
number of previous cessation attempts) in all the three
arms will be expressed as mean values ± standard devia-
tion (SD). The null hypothesis will be adopted in compar-
ing the outcomes (PAR, CAR, CO levels, MNWS score
Figure 3 Figure 3a, b. Auricular acupressure plasters using
Melastoma candidum seeds as beads attached under plasters which
are individually packaged.
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Arm 3, and finally between Arm 1 and Arm 2. In view of
the small sample size for each arm, the Mann-Whitney-
Wilcoxon two-sample rank sum test will be used for each
Arm pair. Medians will be calculated with the quartiles
and the Mann-Whitney U. Where possible, treatment
effect for each Arm pair comparison will be expressed
using the Hodges-Lehmann estimator with the 95% confi-
dence intervals and significance levels.
Adverse events and withdrawal from studies
Part of the objectives of our pilot study is to assess the
possible adverse effects due either to the auricular acu-
pressure or, due to withdrawal and stress from smoking
cessation. The nature and severity of the adverse effects
will be recorded and assessed with the MNWS and SCL
scores. At any time, participants may withdraw from the
study if they develop severe nicotine withdrawal reac-
tions or anxiety symptoms; if they have any adverse
effects of pain, discomfort, inflammation or infection at
the local sites of the plaster; if there is any inter-current
illness that would, in the judgment of the investigators,
affect outcome measures to a significant degree; and
finally, as requested by the participants.
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Consent will be obtained from every participant in a
written form. This study protocol has been peer-
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